{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T11:32:29Z","timestamp":1744716749152},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1097\/mph.0b013e3181639b28","type":"journal-article","created":{"date-parts":[[2008,5,5]],"date-time":"2008-05-05T07:21:27Z","timestamp":1209972087000},"page":"337-342","source":"Crossref","is-referenced-by-count":13,"title":["Recombinant Activated Factor VII as a Hemostatic Agent in Very Low Birth Weight Preterms With Gastrointestinal Hemorrhage and Disseminated Intravascular Coagulation"],"prefix":"10.1097","volume":"30","author":[{"given":"Doris","family":"Fischer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolf","family":"Schloesser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Horst","family":"Buxmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Veldman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-1-20210227","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2174\/0929867033457728","article-title":"New insights into the coagulation system and implications for new therapeutic options with recombinant factor VIIa","volume":"10","author":"Veldman","year":"2003","journal-title":"Curr Med Chem"},{"key":"R2-1-20210227","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1182\/asheducation-2006.1.426","article-title":"Challenges in the therapeutic use of a \u201cso-called\u201d universal hemostatic agent: recombinant factor VIIa","author":"Hoots","year":"2006","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"key":"R3-1-20210227","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/01.moh.0000135405.29702.3c","article-title":"Recombinant activated factor VII for non-hemophiliac bleeding patients","volume":"11","author":"Uhlmann","year":"2004","journal-title":"Curr Opin Hematol"},{"key":"R4-1-20210227","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/ajh.1123","article-title":"Therapeutic choices for patients with hemophilia and high-titer inhibitors","volume":"67","author":"Kulkarni","year":"2001","journal-title":"Am J Hematol"},{"key":"R5-1-20210227","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1542\/peds.110.1.169","article-title":"The use of recombinant activated factor VII to control bleeding in a preterm infant undergoing exploratory laparotomy","volume":"110","author":"Chuansumrit","year":"2002","journal-title":"Pediatrics"},{"key":"R6-1-20210227","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/sj.jp.7210787","article-title":"Treatment of severe pulmonary hemorrhage with activated recombinant factor VII (rFVIIa) in very low birth weight infants","volume":"22","author":"Olomu","year":"2002","journal-title":"J Perinatol"},{"key":"R7-1-20210227","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1007\/s00134-002-1489-x","article-title":"Life-threatening hemorrhage in neonates: management with recombinant activated factor VII","volume":"28","author":"Veldman","year":"2002","journal-title":"Intensive Care Med"},{"key":"R8-1-20210227","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/MPH.0b013e3180335bcb","article-title":"Is the user of rFVIIa safe and effective in bleeding neonates","volume":"29","author":"Mitsiakos","year":"2007","journal-title":"J Pediatr Haematol Oncol"},{"key":"R9-1-20210227","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.jpeds.2005.07.034","article-title":"Spontaneous liver hemorrhage during laparotomy for necrotizing enterocolitis: a potential role for recombinant factor VIIa","volume":"147","author":"Filan","year":"2005","journal-title":"J Pediatr"},{"key":"R10-1-20210227","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1053\/j.seminhematol.2003.11.019","article-title":"Safety profile of recombinant factor VIIa","volume":"41","author":"Roberts","year":"2004","journal-title":"Semin Hematol"},{"issue":"1","key":"R11-1-20210227","first-page":"65","article-title":"Postpartum haemorrhage","volume":"115","author":"McLintock","year":"2005","journal-title":"Thromb Res"},{"key":"R12-1-20210227","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/pbc.20078","article-title":"Management of coagulopathy with recombinant factor VIIa in a neonate with echovirus type 7","volume":"43","author":"Tancabelic","year":"2004","journal-title":"Pediatr Blood Cancer"},{"key":"R13-1-20210227","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000658-197801000-00001","article-title":"Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging","volume":"187","author":"Bell","year":"1978","journal-title":"Ann Surg"},{"key":"R14-1-20210227","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/sj.jp.7211782","article-title":"Emerging trends in acquired neonatal intestinal disease: is it time to abandon Bell's criteria?","volume":"27","author":"Gordon","year":"2007","journal-title":"J Perinatol"},{"key":"R15-1-20210227","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1097\/01.CCM.0000147769.07699.E3","article-title":"Prospective validation of the International Society of thrombosis and Haemostasis scoring system for disseminated intravascular coagulation","volume":"32","author":"Bakhtiari","year":"2004","journal-title":"Crit Care Med"},{"key":"R16-1-20210227","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/00024382-200115050-00003","article-title":"Characterization of multiple organ dysfunction syndrome in very low birthweight infants: a new sequential scoring system","volume":"15","author":"Janota","year":"2001","journal-title":"Shock"},{"key":"R17-1-20210227","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/07853890310017251","article-title":"New treatment strategies for disseminated intravascular coagulation based on current understanding of the pathophysiology","volume":"36","author":"Levi","year":"2004","journal-title":"Ann Med"},{"key":"R18-1-20210227","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1136\/gut.2003.024521","article-title":"The role of platelet activating factor in a neonatal piglet model of necrotising enterocolitis","volume":"53","author":"Ewer","year":"2004","journal-title":"Gut"},{"key":"R19-1-20210227","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1161\/01.CIR.88.3.1205","article-title":"Short-term and long-term role of platelet activating factor as a mediator of in vivo platelet aggregation","volume":"88","author":"Golino","year":"1993","journal-title":"Circulation"},{"key":"R20-1-20210227","doi-asserted-by":"crossref","first-page":"11849","DOI":"10.1074\/jbc.M609283200","article-title":"Endothelial cell protein C receptor acts as a cellular receptor for factor VIIa on endothelium","volume":"282","author":"Ghosh","year":"2007","journal-title":"J Biol Chem"},{"key":"R21-1-20210227","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000205197","article-title":"Disseminated intravascular coagulation and myocardial infarction in a haemophilia B patient during therapy with prothrombin complex concentrates","volume":"83","author":"Chistolini","year":"1990","journal-title":"Acta Haematol"},{"key":"R22-1-20210227","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/S0049-3848(99)00078-X","article-title":"Production and composition of prothrombin complex concentrates: correlation between composition and therapeutic efficiency","volume":"95","author":"Hellstern","year":"1999","journal-title":"Thromb Res"},{"issue":"4","key":"R23-1-20210227","first-page":"S1059","article-title":"Outcome of intracranial hemorrhage in infants with congenital factor VII deficiency","volume":"85","author":"Chuansumrit","year":"2002","journal-title":"J Med Assoc Thai"},{"key":"R24-1-20210227","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1046\/j.1365-2516.2000.00345.x","article-title":"Clinical efficacy and recovery levels of recombinant FVIIa (NovoSeven) in the treatment of intracranial haemorrhage in severe neonatal FVII deficiency","volume":"6","author":"Wong","year":"2000","journal-title":"Haemophilia"},{"key":"R25-1-20210227","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/sj.jp.7211588","article-title":"Recombinant activated factor seven in acute life-threatening bleeding in neonates: report on three cases and review of literature","volume":"26","author":"Hunseler","year":"2006","journal-title":"J Perinatol"},{"key":"R26-1-20210227","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1460-9592.2005.01429.x","article-title":"Recombinant factor VIIa (NovoSeven) as a hemostatic agent after surgery for congenital heart disease","volume":"15","author":"Razon","year":"2005","journal-title":"Paediatr Anaesth"},{"key":"R27-1-20210227","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1213\/01.ANE.0000173666.80578.49","article-title":"Use of recombinant factor VIIa (Novoseven) in combination with other coagulation products led to a thrombotic occlusion of the truncus brachiocephalicus in a neonate supported by extracorporal membrane oxygenation","volume":"101","author":"Velik-Salchner","year":"2005","journal-title":"Anesth Analg"},{"key":"R28-1-20210227","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/01.PCC.0000162449.55887.B9","article-title":"Recombinant factor VII for severe bleeding during extracorporeal membrane oxygenation following open heart surgery","volume":"6","author":"Wittenstein","year":"2005","journal-title":"Pediatr Crit Care Med"},{"key":"R29-1-20210227","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s00431-003-1369-6","article-title":"Refractory bleeding following major surgery of a giant sacrococcygeal teratoma in a premature infant: successful use of recombinant factor VIIa","volume":"163","author":"Girisch","year":"2004","journal-title":"Eur J Pediatr"},{"key":"R30-1-20210227","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2516.2005.01078.x","article-title":"The use of recombinant factor VIIa for bleeding in paediatric practice","volume":"11","author":"Millar","year":"2005","journal-title":"Haemophilia"},{"key":"R31-1-20210227","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/01.PCC.0000185491.17584.4B","article-title":"A prospective pilot study of prophylactic treatment of preterm neonates with recombinant activated factor VII during the first 72 hours of life","volume":"7","author":"Veldman","year":"2006","journal-title":"Pediatr Crit Care Med"},{"issue":"2","key":"R32-1-20210227","doi-asserted-by":"crossref","first-page":"S248","DOI":"10.1007\/s00134-002-1472-6","article-title":"Ongoing NovoSeven trials","volume":"28","author":"Erhardtsen","year":"2002","journal-title":"Intensive Care Med"},{"key":"R33-1-20210227","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1365-2516.2004.00925.x","article-title":"Pharmacokinetics of activated recombinant coagulation factor VII (NovoSeven) in children vs. adults with haemophilia A","volume":"10","author":"Villar","year":"2004","journal-title":"Haemophilia"},{"key":"R34-1-20210227","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1538-7836.2007.02320.x","article-title":"Recombinant activated factor VII efficacy and safety in a model of bleeding and thrombosis in hypothermic rabbits: a blind study","volume":"5","author":"Godier","year":"2007","journal-title":"J Thromb Haemost"},{"key":"R35-1-20210227","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/00005373-200208000-00011","article-title":"The effect of recombinant factor VIIa on coagulopathic pigs with grade V liver injuries","volume":"53","author":"Schreiber","year":"2002","journal-title":"J Trauma"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0b013e3181639b28","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T04:02:41Z","timestamp":1620964961000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-200805000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0b013e3181639b28","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}